SCHEMBL525796

SCHEMBL525796

COc1ccc(C(=O)C2CCN(C3=CC=CNN3C3CCN(Cc4ccc(C#N)cc4)CC3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 1/20 0.53
PRKAG1 P54619 1/20 0.53
PRKAA2 P54646 1/20 0.53
KCNH2 Q12809 1/20 0.53
PRKAA1 Q13131 1/20 0.53
PRKAG3 Q9UGI9 1/20 0.53
PRKAG2 Q9UGJ0 1/20 0.53
PRKAB1 Q9Y478 1/20 0.53
SLC18A3 Q16572 6/20 0.49
CYP3A4 P08684 2/20 0.48
USP2 O75604 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
DRD2 P14416 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16599590 0.82 HRH3 (0.58) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL518740 0.71 PRKAA2 (0.77) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1
SCHEMBL518735 0.71 PRKAA2 (0.70) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1
SCHEMBL30516673 0.71 SLC18A3 (0.74) SLC18A3TSHRSMN1; SMN2MEN1KMT2A
SCHEMBL1035332 0.70 PRKAA2 (0.69) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1
SCHEMBL517986 0.69 PRKAB2 (1.00) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1
SCHEMBL518414 0.69 PRKAB2 (0.83) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1
SCHEMBL10284366 0.68 PRKAB2 (0.86) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1
SCHEMBL518529 0.68 PRKAA2 (0.90) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1
SCHEMBL518679 0.68 PRKAB2 (0.87) PRKAB2PRKAG1PRKAA2KCNH2PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 EP claimed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 WO claimed